Open Accessibility Menu

Early Stage investment

Late seed to series B funding for ambitious startups

Our Early Stage team back founders across the UK and Ireland that are turning bold, breakthrough ideas into world-leading businesses in deep tech and life sciences. We provide startups with an initial investment of £3m-£10m, plus access to follow-on funding, deep domain expertise, and ongoing support for their growth plans.

How we're different

We’re uniquely equipped to provide early-stage venture capital, but backed by the platform and resources of a later-stage growth investor:

  • Deep technical and commercial expertise
  • Evergreen fund structure, purpose-built to drive long-term growth
  • Specialist team of early-stage investors to support you as you scale
  • Built on a foundation of 600+ investments and 200+ exits, across the full BGF portfolio

Deep tech

We back pioneering technologies, grounded in scientific and engineering excellence, across:

  • Semiconductors and photonics
  • Advanced materials
  • AI and software platforms
  • Energy storage and management
  • Energy and resource efficiency
Gaussion leadership team

Life sciences

We’re helping to turn world-class research and scientific discovery into meaningful patient outcomes in these verticals:

  • Drug discovery and development
  • MedTech
  • Diagnostics
  • Advanced tools and materials
Mixed-gender leadership team of BGF-backed life sciences startup TidalSense

Accelerating impact

Our Early Stage investors bring together deep domain knowledge, venture capital experience and commercial insight. Since 2019, we’ve built a track record of scaling science-led innovation into global success:

  • £325m+ investment deployed
  • 70+ companies backed
  • 140+ transactions completed
BGF Early Stage investment team

Investment criteria

To be eligible for funding and support from our Early Stage team, businesses must meet these criteria:

  • Headquartered in the UK or Ireland
  • Privately-owned
  • Operating in deep tech or life sciences
  • IP-protected
  • Late seed to series B
  • Seeking £3m-£10m initial investment from BGF
  • “BGF brings the best of both worlds: the backing of a major fund and the hands-on support of people who really care about founders.”

    Tom Heenan, Co-Founder & CEO of Gaussion
  • “BGF is set apart by their ability to take a long-term view, having supported us across six funding rounds, taking us from lab-scale to a global leader.”

    Craig Marshall, CEO at OrganOx
  • “What sets BGF apart is their understanding of deep tech. They grasp the complexity and the opportunity, and they’ve been with us every step of the journey.”

    Jean de la Verpilliere, Co-Founder & CEO of Echion